3 Best Stocks Under $20 According to Billionaire Andreas Halvorsen’s Viking Global

Page 1 of 3

In this article, we take a look at the 3 best stocks under $20 according to billionaire Andreas Halvorsen’s Viking Global. If you want to see our detailed analysis of Andreas Halvorsen’s hedge fund performance, early life, and biography, go directly to 7 Best Stocks Under $20 According to Billionaire Andreas Halvorsen’s Viking Global.

3. Talaris Therapeutics, Inc. (NASDAQ:TALS)

Stake Value of Viking Global: $48,324,000 

Share Price: $14.87

Percentage of Viking Global’s 13F Portfolio: 0.14%

Number of Hedge Fund Holders: 16

Talaris Therapeutics, Inc. (NASDAQ:TALS) operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and metabolic disorders. Talaris Therapeutics, Inc. (NASDAQ:TALS) was founded in 1988 and is headquartered in Louisville, Kentucky.

This June, Evercore ISI analyst Josh Schimmer initiated coverage of Talaris Therapeutics, Inc. (NASDAQ:TALS) with an Outperform rating and $35 price target.

According to Q2 filings, Mr. Halvorsen owns over 3.28 million shares of Talaris Therapeutics, Inc. (NASDAQ:TALS). This amounts to a total stake value of $48.3 million which covers an impressive 0.14% of the billionaire’s investment portfolio.

By the end of the second quarter of 2021, 16 hedge funds out of the 873 tracked by Insider Monkey held stakes in Talaris Therapeutics, Inc. (NASDAQ:TALS) worth more than $150.4 million.

Page 1 of 3